1. Home
  2. FNF vs WAT Comparison

FNF vs WAT Comparison

Compare FNF & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNF
  • WAT
  • Stock Information
  • Founded
  • FNF 1847
  • WAT 1958
  • Country
  • FNF United States
  • WAT United States
  • Employees
  • FNF N/A
  • WAT N/A
  • Industry
  • FNF Specialty Insurers
  • WAT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • FNF Finance
  • WAT Industrials
  • Exchange
  • FNF Nasdaq
  • WAT Nasdaq
  • Market Cap
  • FNF 16.0B
  • WAT 17.4B
  • IPO Year
  • FNF N/A
  • WAT 1995
  • Fundamental
  • Price
  • FNF $56.58
  • WAT $351.08
  • Analyst Decision
  • FNF Strong Buy
  • WAT Buy
  • Analyst Count
  • FNF 5
  • WAT 15
  • Target Price
  • FNF $71.00
  • WAT $373.13
  • AVG Volume (30 Days)
  • FNF 939.3K
  • WAT 676.7K
  • Earning Date
  • FNF 11-05-2025
  • WAT 11-04-2025
  • Dividend Yield
  • FNF 3.54%
  • WAT N/A
  • EPS Growth
  • FNF 16.93
  • WAT 10.77
  • EPS
  • FNF 3.93
  • WAT 11.09
  • Revenue
  • FNF $13,634,000,000.00
  • WAT $3,046,056,000.00
  • Revenue This Year
  • FNF $1.15
  • WAT $7.15
  • Revenue Next Year
  • FNF $10.81
  • WAT $6.34
  • P/E Ratio
  • FNF $14.36
  • WAT $31.45
  • Revenue Growth
  • FNF 7.26
  • WAT 5.89
  • 52 Week Low
  • FNF $50.61
  • WAT $275.05
  • 52 Week High
  • FNF $66.72
  • WAT $423.56
  • Technical
  • Relative Strength Index (RSI)
  • FNF 44.96
  • WAT 72.65
  • Support Level
  • FNF $54.60
  • WAT $323.46
  • Resistance Level
  • FNF $57.09
  • WAT $364.99
  • Average True Range (ATR)
  • FNF 1.15
  • WAT 9.69
  • MACD
  • FNF -0.03
  • WAT 2.11
  • Stochastic Oscillator
  • FNF 35.44
  • WAT 69.53

About FNF FNF Group of Fidelity National Financial Inc.

Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. Substantially all of the company's revenue is generated in the United States.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: